Develop and Manufacture RNA Medicines for the Treatment of COVID-19 faster and more reliably

Learn how the PNI NanoAssemblr Ignite supports: 1. Development of COVID-19 RNA-LNP vaccine 2. Proprietary lipid formulations (RNA delivery technology) 3. Scale-up and manufacturing technology for RNA-LNPs therapeutics 4. Formulation development, optimisation and planning scale-up and tech     transfer for GMP manufacturing PRESS RELEASES: Moderna  Announces Positive Interim Phase 1 Data for its mRNA Vaccine Against Novel Coronavirus; CanSino adds mRNA to COVID-19 vaccine efforts with Precision NanoSystems deal CONTACT US FOR A DEMO     WATCH THIS WEBINAR How to Formulate Lipid Nanoparticles with GenVoy-ILM During this demo Dr. Shell Ip, works through an example of encapsulating an RNA with GenVoy-ILM with the NanoAssemblr® Ignite.     WATCH THIS WEBINAR Self-Amplifying RNA Vaccine against COVID-19 Dr. Anna Blakney from Imperial College London will provide insight into vaccine design using saRNA encoding the SARS-CoV-2 spike protein encapsulated within a lipid nanoparticle & evaluate immunogenicity and rapid translation to the clinic.    WATCH THIS WEBINAR Developing RNA Medicines for the Treatment of Pandemics Learn more about some of the key considerations for developing a RNA medicine as a rapid response for treatment and prevention of pandemics with Dr. Andy Geall and Dr. Lloyd Jeffs.   WATCH THIS WEBINAR Early Preclinical Development of mRNA Therapeutics This session will take a closer look at the Early Preclinical development stage and examine fundamental aspects of developing LNP formulations for gene delivery including process parameters and chemistry.   WATCH THIS WEBINAR PTXmRNA and PTXcLNP – a new class of therapeutics for the treatment of vascular indications Webinar by Dr Daniel Tondera, Head of Biology, Pantherna Therapeutics GmbH.     Need a Portable CO2 incubator for transporting fragile and valuable cells around facilities? * APPLICATIONS BIO ASSAYS:  Lab-on-a Chip, Organ-on-a-Chip, On-site/In-field experiments, Cell Toxicity, Microfluidics CELL STORAGE: Cell Bank, Cryo Banks MANUFACTURING CELLS: Primary Cell Cultures, Stem Cells 3D-CELL CULTURE: Tissue Engineering, Organoids, 3D-Bioprinting   CONTACT US FOR A DEMO     ATA Scientific has developed a COVID-19 Customer Response Plan to help those that require analytical testing services adapted to the remote working environment.  Our technical support and service team is ready to support you remotely with web based demonstrations, online operator training, service support, contract sample testing and instrument hire. Click here to read more